Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M.C. Telgen, M.G.J. Brusse-Keizer, P.D.L.P.M. van der Valk, J. van der Palen, H.A.M. Kerstjens, M.G.R. Hendrix (Enschede, Netherlands). Procalcitonin and proadrenomedullin in COPD patients: Stable state versus exacerbation difference in mortality rate?. Eur Respir J 2012; 40: Suppl. 56, 2502

Member's Comments

No comment yet.

Related content which might interest you: Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients Source: International Congress 2014 – Comorbidities Year: 2014 Does higher DECAF score increase length of hospital stay in acute exacerbation of COPD? Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Aspergillus in COPD patients; is it a predictor for mortality? Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Determinants of exacerbation rate in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 MR-proANP predicts 2-year survival in patients admitted for acute exacerbation of COPD Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD) Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015 BNP is a predictor of mortality following COPD exacerbations Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011